The reason for recall is “failed impurities/degradation: out of specification result for impurity secorapamycin,” says report.
Shares of Dr Reddy’s Laboratories was lower by 1% to Rs.3574. The company recalled 9,330 bottles of Sirolimus tablets, used for prevention of organ rejection after kidney transplant, in the US due to presence of impurities, says report.
The reason for recall is “failed impurities/degradation: out of specification result for impurity secorapamycin,” says report.
The scrip opened at Rs. 3587 and has touched a high and low of Rs. 3587 and Rs. 3562.2 respectively. So far 19256(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 61584.4 crore.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016. Last one week high and low of the scrip stood at Rs. 3633 and Rs. 3475.4 respectively.
The promoters holding in the company stood at 25.58 % while Institutions and Non-Institutions held 42.02 % and 32.4 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment